Weight loss care is leading IPO-hopeful Omada Health's latest growth surge as Ozempic boom continuesOmada Health's weight loss program is driving its growth and public market ambitions, with a notable shift towards GLP-1 care.
NHS soup and shake' diet puts almost a third of type 2 diabetes cases in remissionOffering an 800-calorie-a-day soup and shake diet to people with type 2 diabetes in England can lead to one in three permanently reversing their condition.